StockData
Becton Dickinson & Co logo

Becton Dickinson & Co

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3018% above fair value
$216.08+0.66 (+0.31%)

Close on Nov 18, 2026Market cap $58.86BP/E 65.3Yield 1.93%

Becton Dickinson LTM Adjusted EBITDA — Continuing Operations by Quarter

LTM Adjusted EBITDA — Continuing Operations ($M) ($M)

Periods

Becton Dickinson LTM Adjusted EBITDA — Continuing Operations: $5,842M in Q4 FY26.

Latest, Q4 FY26
5,842
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
–
History
5 quarters
Since Q4 FY23
Sources
5
Documents cited below

Where the Q4 FY26 figure comes from

“Adjusted EBITDA $ 5,842”

Source: BD Q4 FY2026 Earnings Presentation ↗

Reported in BD Quarterly Earnings Presentations — Net Leverage Reconciliation.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLTM Adjusted EBITDA — Continuing Operations ($M) ($M)Year on yearSource
Q4 FY26CQ3 2026Sep 30, 20265,842–BD Q4 FY2026 Earnings Presentation ↗
Q3 FY26CQ2 2026Jun 30, 20265,609–BD Q3 FY2026 Earnings Presentation ↗
Q2 FY26CQ1 2026Mar 31, 20265,609–BD Q2 FY2026 Earnings Presentation ↗
Q1 FY24CQ4 2023Dec 31, 20235,561–BD Q1 FY2024 Earnings Presentation ↗
Q4 FY23CQ3 2023Sep 30, 20235,659–BD Q4 FY2023 Earnings Presentation ↗

Breakdown

What makes up LTM Adjusted EBITDA — Continuing Operations

Cite this data

StockData. (2026). Becton Dickinson LTM Adjusted EBITDA — Continuing Operations ($M), quarterly Q4 FY23–Q4 FY26 [Data set]. Compiled from Becton Dickinson SEC filings and investor materials. https://stockdatahq.com/stocks/bdx/kpis/lev-ebitda

See every metric in the Becton Dickinson KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?